Altimmune Inc (ALT)
6.74
0.00 (0.00%)
USD |
NASDAQ |
Nov 01, 16:00
6.70
-0.04
(-0.59%)
After-Hours: 20:00
Altimmune 1 Year Total Returns (Daily): 175.1% for Nov. 1, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
November 01, 2024 | 175.1% |
October 31, 2024 | 179.7% |
October 30, 2024 | 182.8% |
October 29, 2024 | 218.6% |
October 28, 2024 | 203.5% |
October 25, 2024 | 182.3% |
October 24, 2024 | 186.7% |
October 23, 2024 | 214.0% |
October 22, 2024 | 213.4% |
October 21, 2024 | 218.0% |
October 18, 2024 | 173.0% |
October 17, 2024 | 157.2% |
October 16, 2024 | 149.5% |
October 15, 2024 | 164.7% |
October 14, 2024 | 141.7% |
October 11, 2024 | 120.3% |
October 10, 2024 | 120.5% |
October 09, 2024 | 138.7% |
October 08, 2024 | 147.6% |
October 07, 2024 | 142.1% |
October 04, 2024 | 148.2% |
October 03, 2024 | 152.0% |
October 02, 2024 | 146.9% |
October 01, 2024 | 141.9% |
September 30, 2024 | 136.2% |
Date | Value |
---|---|
September 27, 2024 | 156.7% |
September 26, 2024 | 170.2% |
September 25, 2024 | 178.9% |
September 24, 2024 | 172.8% |
September 23, 2024 | 175.9% |
September 20, 2024 | 188.5% |
September 19, 2024 | 163.8% |
September 18, 2024 | 174.2% |
September 17, 2024 | 159.2% |
September 16, 2024 | 159.6% |
September 13, 2024 | 195.1% |
September 12, 2024 | 172.0% |
September 11, 2024 | 195.1% |
September 10, 2024 | 184.1% |
September 09, 2024 | 160.4% |
September 06, 2024 | 149.0% |
September 05, 2024 | 154.6% |
September 04, 2024 | 145.3% |
September 03, 2024 | 140.8% |
August 30, 2024 | 168.0% |
August 29, 2024 | 167.6% |
August 28, 2024 | 170.0% |
August 27, 2024 | 179.2% |
August 26, 2024 | 185.8% |
August 23, 2024 | 172.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-88.80%
Minimum
Sep 05 2023
1.32K%
Maximum
Jul 20 2020
116.3%
Average
10.17%
Median
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 48.68% |
Viking Therapeutics Inc | 661.5% |
Amgen Inc | 26.08% |
Avid Bioservices Inc | 75.56% |
NovaBay Pharmaceuticals Inc | -93.74% |